Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novo-Nordisk
Company Monitoring Page for Novo-Nordisk
latest headlines for company on cafepharma
Nordisk touts Tresiba insulin injection data
Drug Delivery Business
Thu, 12/1/16 - 09:51 am
Tags:
Novo Nordisk
,
Tresiba
,
insulin
,
diabetes
,
insulin injection
These drug and medical device companies made $5.6 million in nonresearch payments to Washington hospitals last year
Bizjournals.com
Wed, 11/30/16 - 09:54 am
Tags:
Novo Nordisk
,
hospitals
,
physician payments
Novo Nordisk’s Diabetes Drug Gets FDA OK
Investopedia
Tue, 11/22/16 - 09:53 pm
Tags:
Novo Nordisk
,
FDA
,
diabetes
,
Xultophy
Novo Nordisk: This Is All You Need To Know Right Now
Seeking Alpha
Mon, 11/14/16 - 10:23 am
Tags:
Novo Nordisk
World Leader in Diabetes Medication Hits 2-Year Low
Yahoo/GuruFocus
Mon, 11/7/16 - 09:30 pm
Tags:
diabetes
,
Novo Nordisk
Bernie Sanders calls for federal investigation of insulin makers for price collusion
Stat/Pharmalot
Fri, 11/4/16 - 10:21 am
Tags:
Bernie Sanders
,
drug pricing
,
insulin
,
diabetes
,
price collusion
,
Eli Lilly
,
Novo Nordisk
,
Sanofi
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
Bloomberg
Fri, 11/4/16 - 09:42 am
Tags:
collusion
,
DOJ
,
generics
,
Sanofi
,
Eli Lilly
,
Merck
,
Novo Nordisk
,
Mylan Labs
,
drug pricing
Safety issues with Roche drug good for Novo Nordisk
BioPharma Dive
Thu, 11/3/16 - 01:30 pm
Tags:
Roche
,
Novo Nordisk
,
ACE910
,
emicizumab
,
hemophilia
US Still the Largest Market for Novo Nordisk
Market Realist
Wed, 11/2/16 - 09:50 am
Tags:
Novo Nordisk
,
diabetes
,
United States
New Novo Nordisk Strategy Drops Oral Insulin, Expands Oral GLP-1
Seeking Alpha
Sun, 10/30/16 - 11:14 am
Tags:
Novo Nordisk
,
diabetes
,
oral insulin
,
insulin
,
GLP-1 agonist
,
R&D
Novo equipped to weather the storm in the U.S. diabetes market, CEO says
Fierce Pharma
Sat, 10/29/16 - 01:22 pm
Tags:
Novo Nordisk
,
diabetes
,
Lars Sorenson
,
drug pricing
Novo Nordisk Stock Plunges as U.S. Problems Cloud Outlook
TheStreet.com
Fri, 10/28/16 - 10:17 am
Tags:
Novo Nordisk
,
earnings
Departing Novo chief wins 'best CEO' nod again, and Biogen's grabs laurels, too
Fierce Pharma
Thu, 10/13/16 - 10:56 am
Tags:
Pharma CEOs
,
Novo Nordisk
,
Biogen
,
Lars Sorenson
,
George Scangos
Why Novo Nordisk Stock Fell 10.2% in September
Motley Fool
Sat, 10/8/16 - 03:50 pm
Tags:
Novo Nordisk
,
reorganization
,
layoffs
Novo Nordisk eyes drug development program
Mass Device
Tue, 10/4/16 - 10:15 am
Tags:
Novo Nordisk
,
diabetes
,
drug development
Why Novo Nordisk Expects Double-Digit Growth in Diabetes Care in 2016
Market Realist
Fri, 09/30/16 - 01:06 pm
Tags:
Novo Nordisk
,
diabetes
U.S. payer pressures force Novo Nordisk to cut loose 1,000 staffers
Fierce Pharma
Thu, 09/29/16 - 08:25 am
Tags:
Novo Nordisk
,
layoffs
,
R&D
Which drugmakers have the healthiest presence on social media?
Medical Marketing and Media
Wed, 09/28/16 - 10:40 am
Tags:
social media
,
Eli Lilly
,
JNJ
,
Boehringer Ingelheim
,
Novo Nordisk
Novo Shows Its Devotion To Tresiba's Cause
Seeking Alpha
Wed, 09/28/16 - 10:20 am
Tags:
Novo Nordisk
,
diabetes
,
insulin
,
Tresiba
Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent
Yahoo/Reuters
Sat, 09/17/16 - 01:16 pm
Tags:
Novo Nordisk
,
semaglutide
,
diabetes
Pages
« first
‹ previous
…
36
37
38
39
40
41
42
43
44
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.